
Please try another search
Investing.com -- Zealand Pharma shares surged more than 41% on Wednesday after announcing a $5.3 billion licensing deal with Roche for its GLP-1 obesity therapy petrelintide. The agreement gives...
Investing.com -- Novo Nordisk (CSE:NOVOb) (NYSE:NVO) shares slumped Wednesday after Roche (SIX:ROG) struck a $5.3 billion deal to acquire rights to an obesity treatment from Denmark’s Zealand...
Investing.com -- Roche Holding AG (OTC:RHHVF) has enlisted the expertise of Morten Lammert, a senior executive from rival firm Novo Nordisk (NYSE:NVO) A/S, as they gear up to break into the highly...
Investing.com -- UBS made key adjustments to its ratings on major European pharmaceutical companies, downgrading Novartis (SIX:NOVN) while upgrading Roche and AstraZeneca (NASDAQ:AZN) in notes on...
Roche on Monday revealed positive results from the EMBARK trial, showing that its gene therapy Elevidys has sustained benefits for individuals with Duchenne muscular dystrophy (DMD) over a two-year...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review